Chronic inflammation experienced by RA subjects may drive SP1 and IL-21R expression, promoting IL-6 production and the expansion of the autoantigen specific B cells ultimately contributing to the expanding specificities of ACPA and the maturation of high affinity responses seen in RA over time. The gene discussed is SP1; the disease is rheumatoid arthritis.